Share This Post

Breakthrough designation for Keytruda/Lenvima in kidney cancer

Read more here: https://www.fiercepharma.com/pharma/merck-eisai-nab-keytruda-lenvima-breakthrough-quickly-crowding-kidney-cancer-field

Share This Post

Dena Battle is the President of KCCure. She also serves on the Advisory Board for the Johns Hopkins Sidney Kimmel Cancer Center and as a member of the Patient and Family Advisory Council.

Lost Password

Register

Subscribe for updates!